臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

跳至:
或輸入年份:

從最近的開始

由舊到新排序

顯示項目 2288276-2288285 / 2346460 (共234646頁)
<< < 228823 228824 228825 228826 228827 228828 228829 228830 228831 228832 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2022-08-19T00:21:03Z	Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma	Cheng A.-L.; Ding Y.-H.; CHIUN HSU; Shao Y.-Y.; Chen P.-J.; Lin Z.-Z.; Shen Y.-C.; Hsu C.-H.
臺大學術典藏	2022-08-19T00:21:04Z	Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa B	Liou J.-Y.; Shyue S.-K.; Chang C.-C.; Golubovskaya V.M.; Shen T.-L.; Shen Y.-C.; CHIUN HSU; Kuo C.-C.; Ko B.-S.; Chang T.-C.; Chen C.-H.; Liu C.-C.
臺大學術典藏	2022-08-19T00:21:04Z	Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design	CHIUN HSU; Shen Y.-C.; Cheng C.-C.; Hu F.-C.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:21:04Z	Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma	Jan Y.-J.; Ko B.-S.; CHIUN HSU; Chang T.-C.; Chen S.-C.; Wang J.; Liou J.-Y.
臺大學術典藏	2022-08-19T00:21:04Z	Sorafenib for the treatment of hepatocellular carcinoma across geographic regions	CHIUN HSU; Shen Y.-C.; Cheng A.L.
臺大學術典藏	2022-08-19T00:21:05Z	Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway	Chen K.-F.; Yeh P.-Y.; CHIUN HSU; Hsu C.-H.; Lu Y.-S.; Hsieh H.-P.; Chen P.-J.; Cheng A.-L.
臺大學術典藏	2022-08-19T00:21:05Z	Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma	Cheng A.-L.; CHIUN HSU; Wang D.-S.; Lu Y.-S.; Fan H.-H.; Ou D.-L.; Shen Y.-C.; Liang J.-D.; Liou J.-Y.; Yu S.-L.
臺大學術典藏	2022-08-19T00:21:06Z	Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: Correlation with clinicopathologic features and patient survival	Shen Y.-C.; Hu F.-C.; Jeng Y.-M.; Chang Y.-T.; Lin Z.-Z.; Chang M.-C.; CHIUN HSU; Cheng A.-L.
臺大學術典藏	2022-08-19T00:21:07Z	Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-A randomized phase II trial	CHIUN HSU; Kuo S.-H.; Hu F.-C.; Cheng A.-L.; Shih J.-Y.; Yu C.-J.; Lin C.-C.; Huang T.-C.; Yang P.-C.; Yang C.-H.
臺大學術典藏	2022-08-19T00:21:07Z	Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer	Chang Y.-T.; Chang M.-C.; Wei S.-C.; Tien Y.-W.; CHIUN HSU; Liang P.-C.; Tsao P.-N.; Jan I.-S.; Wong J.-M.

顯示項目 2288276-2288285 / 2346460 (共234646頁)
<< < 228823 228824 228825 228826 228827 228828 228829 228830 228831 228832 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2853535
	造訪人次 : 45238607 線上人數 : 818 教育部委託研究計畫計畫執行:國立臺灣大學圖書館